FluoroPharma Medical, Inc.

OTC: FPMI · Healthcare · Biotechnology

PublicHQ Montclair, NJReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 30

v0.1 · 5/100 weight · pillars only

↑ listing tenure, disclosure history · ↓ Piotroski F, balance-sheet leverage

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$2.0M

Employees

Market cap

$6.9k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02016

Net income-$2.0M-$2.0M2016

Operating income-$2.2M-$2.2M2016

Total assets$334.8k$334.8k2016

Liabilities$10.5M$10.5M2016

Equity-$10.2M-$10.2M2016

Revenue trend

FY2007 – FY2016 · USD

$110.9k

FY07

$165.9k

FY08

FY13

FY14

FY15

FY16

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

FluoroPharma Medical, Inc. booked $0 in FY2016 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

WOWI, Inc.——AllStar Health Brands Inc——Entia Biosciences, Inc.——RepliCel Life Sciences Inc.——

Key facts

CEOEdward L. Lyons Jr.

SectorHealthcare

IndustryBiotechnology

HeadquartersMontclair, NJ

ExchangeOTC: FPMI

Employees4

IPO date2011-05-16

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.